What is he best known for?
The fields of study he is best known for:
- Surgery
- Cancer
- Internal medicine
Ara A. Vaporciyan spends much of his time researching Surgery, Radiation therapy, Radiology, Lung and Respiratory disease.
His studies deal with areas such as Cancer, Esophageal cancer and Pneumonectomy as well as Surgery.
His Radiation therapy study incorporates themes from Esophagitis, Carcinoma and Phases of clinical research.
Ara A. Vaporciyan has included themes like Nuclear medicine, Mesothelioma, Circulatory system and Extrapleural Pneumonectomy in his Radiology study.
The various areas that he examines in his Lung study include Immunology, Immune system and Myeloperoxidase.
His research on Respiratory disease also deals with topics like
- Propensity score matching that connect with fields like Adjuvant therapy and Cohort,
- Stage, which have a strong connection to Lung cancer, Clinical endpoint, Prospective cohort study, Incidence and Hazard ratio.
His most cited work include:
- C5a-induced expression of P-selectin in endothelial cells. (390 citations)
- Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients (245 citations)
- Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer (244 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Surgery, Lung cancer, Internal medicine, Oncology and Cancer.
Much of his study explores Surgery relationship to Esophageal cancer.
He interconnects Chemoradiotherapy and Esophageal disease in the investigation of issues within Esophageal cancer.
The Lung cancer study combines topics in areas such as Stage, Cancer research and Chemotherapy.
His Oncology study combines topics in areas such as Neoadjuvant therapy and Major Pathologic Response.
His Adenocarcinoma research is multidisciplinary, incorporating perspectives in Carcinogenesis and Lung.
He most often published in these fields:
- Surgery (41.94%)
- Lung cancer (27.86%)
- Internal medicine (27.27%)
What were the highlights of his more recent work (between 2018-2021)?
- Lung cancer (27.86%)
- Internal medicine (27.27%)
- Cancer research (7.62%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Lung cancer, Internal medicine, Cancer research, Surgery and Adenocarcinoma.
His Lung cancer research includes elements of Neoadjuvant therapy, Cancer and Neutrophilia.
His studies deal with areas such as Gastroenterology and Oncology as well as Internal medicine.
His Cancer research research incorporates themes from Tumor microenvironment, T cell, Immune system, Cancer cell and Cytotoxic T cell.
His Esophagectomy research extends to Surgery, which is thematically connected.
As part of one scientific family, he deals mainly with the area of Adenocarcinoma, narrowing it down to issues related to the Lung, and often Radiology, Stage, Exome sequencing and Carcinoma.
Between 2018 and 2021, his most popular works were:
- Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC): Clinical and correlative results from the NEOSTAR study. (62 citations)
- Comprehensive T cell repertoire characterization of non-small cell lung cancer (41 citations)
- Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer (38 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
Internal medicine, Lung cancer, Oncology, Confidence interval and Lung are his primary areas of study.
His work on Chemotherapy and Cytokine is typically connected to Absolute neutrophil count as part of general Internal medicine study, connecting several disciplines of science.
His Lung cancer research includes themes of Tumor necrosis factor alpha, Cancer research, Immune system, Immunotherapy and Perioperative.
His Confidence interval research integrates issues from Metastasectomy and Proportional hazards model.
His Lung research focuses on Carcinoma and how it relates to Microwave ablation.
His Propensity score matching study is related to the wider topic of Surgery.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
